Sharp Increase in Cancer Incidence and Mortality From 2020-2040
Cancer incidence is set to increase by over one fifth by 2040 while cancer mortality will increase by almost one third across the European region, […]
Home »
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration […] Sign up for Daily Star Hot Topics newsletter for the most exciting real life, fashion and sex tips HOT off the press “Pretty girls don’t […] Pioneering mouse study offers new therapeutic avenues for reducing visceral fat stores, which have been associated with cardiovascular disease and multiple types of cancer. Obesity […] To several U.S. senators, it looked wasteful, even outrageous. Every year, taxpayers pay for at least $750 million worth of expensive pharmaceuticals that are simply […] Alcohol consumption is a major risk factor for several cancers including head & neck (mouth, pharynx, larynx), oesophageal and bowel cancer – as well as […] Researchers at The University of Texas MD Anderson Cancer Center have discovered a critical new factor in regulating phenylalanine metabolism and, therefore, in preventing the […] Cancer cells sometimes develop resistance to the cytotoxic drugs used in chemotherapy. Figuring out why the treatment isn't working and why it may even defeat […] The US Food and Drug Administration (FDA) has fully approved the combination of the immunotherapy pembrolizumab (Keytruda) plus the multiple receptor tyrosine kinase inhibitor lenvatinib (Lenvima) […] Doctors and patients are being advised to reduce unnecessary antibiotic use following new data suggesting that these medicines may increase the risk of cancer of […] Two recent collaborative publications by CU Cancer Center members provide insights into how chronic inflammation can serve as a key factor in the development of […] For three years, Alana Severs was embarrassed by a weird line on her fingernail and she covered it up with red nail polish. After reading […] Testicular cancer is the most common solid tumor affecting young men between the ages of 15 and 35 years old. It’s important to know it […] Pancreatic cancer is one of the deadliest cancer subtypes not just because it is difficult to diagnose early, but because it is inherently resistant to […] Most Americans should get screened for colorectal cancer beginning at age 45 instead of age 50, according to new recommendations from the U.S. Preventive Services […] Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National […] Melanocytic nevi, or moles, are nonmalignant growths that arise from pigment producing cells of the skin. They are mostly found in sun-exposed areas; however, they […] A novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma. Using […]
New data shows benefit of drug combination for metastatic castration resistant prostate cancer
‘I was told pretty girls don’t get cancer before terminal diagnosis at 16’
New discovery offers several approaches to fight visceral obesity
National academies’ report took pharma-friendly stance after millions in gifts from drugmakers
Alcohol consumption increases risk of several cancers while coffee protects against liver, skin cancer
Research suggests potential new treatment strategy for phenylketonuria
Research explores how cancer cells develop resistance to chemotherapy
FDA Fully Approves Combination for Advanced Endometrial Cancer
Bowel cancer data reinforce need to reduce unnecessary antibiotic use
Two CU Cancer Center studies provide insights into the link between inflammation and leukemia
Woman discovers line on her fingernail was a rare sign of cancer
Testicular Cancer
Researchers clarify cellular processes related to radiation resistance of pancreatic cancer cells
New national screening guidelines on colorectal cancer
Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting
Study describes differences between mutation profile of acral nevi and acral melanoma
Novel approach to immunotherapy design could pave the way for new brain cancer treatments